About this trial
The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions:
• Does the revised method of compression improve lymph movement and lymphatic propulsion?
Eligibility criteria
Qualifiers
18 years of age or older
A diagnosis of active lower extremity lymphedema, as assessed by medical history
Participant is a candidate for APCD treatment per the Flexitouch Plus indications for use
Must be able to provide informed consent prior to study participation
Disqualifiers
Heart failure (acute pulmonary edema, decompensated acute heart failure)
Acute venous disease (acute thrombophlebitis, acute deep venous thrombosis, acute pulmonary embolism)
Severe peripheral artery disease (critical limb ischemia, including ischemic rest pain, arterial wounds or gangrene)
Active skin or limb infection/inflammatory disease (acute cellulitis, other uncontrolled skin or untreated inflammatory skin disease) on the trunk or lower extremities
Trial design
Treatments tested in this trial
- Advanced pneumatic compression device (APCD)
- Advanced pneumatic compression device (APCD) with revised compression programming
- Indocyanine Green (IC-Green)